These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 2831906)
1. Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man. Gespach C; Bawab W; Chastre E; Emami S; Yanaihara N; Rosselin G Biochem Biophys Res Commun; 1988 Mar; 151(2):939-47. PubMed ID: 2831906 [TBL] [Abstract][Full Text] [Related]
2. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C; Bawab W; de Cremoux P; Calvo F Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044 [TBL] [Abstract][Full Text] [Related]
3. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439 [TBL] [Abstract][Full Text] [Related]
5. VIP receptors from porcine liver: high yield solubilization in a GTP-insensitive form. Voisin T; Couvineau A; Guijarro L; Laburthe M Life Sci; 1991; 48(2):135-41. PubMed ID: 1847224 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of VIP receptors in human lung membranes. Robberecht P; Waelbroeck M; de Neef P; Camus JC; Coy DH; Christophe J Peptides; 1988; 9(2):339-45. PubMed ID: 2836826 [TBL] [Abstract][Full Text] [Related]
7. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology. Gespach C; Bataille D; Vauclin N; Moroder L; Wünsch E; Rosselin G Peptides; 1986; 7 Suppl 1():155-63. PubMed ID: 3018694 [TBL] [Abstract][Full Text] [Related]
8. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
9. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts. Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146 [TBL] [Abstract][Full Text] [Related]
10. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking. McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170 [TBL] [Abstract][Full Text] [Related]
11. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes. Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373 [TBL] [Abstract][Full Text] [Related]
12. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung. Dickinson KE; Schachter M; Miles CM; Coy DH; Sever PS Peptides; 1986; 7(5):791-800. PubMed ID: 3025822 [TBL] [Abstract][Full Text] [Related]
13. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes. Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology and molecular identification of secretin receptors in rat gastric glands. Bawab W; Gespach C; Marie JC; Chastre E; Rosselin G Life Sci; 1988; 42(7):791-8. PubMed ID: 3339956 [TBL] [Abstract][Full Text] [Related]
15. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes. Wanke IE; Rorstad OP Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675 [TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex. Couvineau A; Gammeltoft S; Laburthe M J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175 [TBL] [Abstract][Full Text] [Related]
17. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site. Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin. Andersson M; Carlquist M; Maletti M; Marie JC FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169 [TBL] [Abstract][Full Text] [Related]
20. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle. Guijarro LG; Rodriguez-Pena MS; Prieto JC Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]